Clinical Updates

New data raising safety concerns for Pfizer Inc’s experimental arthritis drug sent its shares down 3 percent, while lifting shares… »   

Illicit drug overdose deaths declined dramatically after the establishment of North America’s first supervised injection facility located in Vancouver, Canada,… »   

In the past 12 years, four large-scale efficacy trials of HIV vaccines have been conducted in various populations. Results from… »   

A needle-in-the-haystack search through nearly 390,000 chemical compounds had led scientists to a substance that can sneak through the protective… »   

An experimental drug that blocks two points of a crucial cancer cell signaling pathway inhibits the growth of ovarian cancer… »   

The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device device has opened the door for… »   

A new study led by Allison Kempe, MD, MPH, professor of Pediatrics at the University of Colorado School of Medicine… »   

Drugs already in development to treat Alzheimer’s disease may eventually be tapped for a different purpose altogether: re-growing the ends… »   

A U.S. advisory panel backed cancer drugs by Pfizer Inc and Novartis AG for treating a rare kind of pancreatic… »   

People who are prescribed certain antibiotics for acne - even those who take them for months at a time -… »   

A study led by researchers at the University of Michigan Comprehensive Cancer Center showed in animal studies that new cancer… »   

An analysis of data from 10 studies indicates that the presence of low frequency (also called “minority”) human immunodeficiency virus… »   

Researchers at the University of Pennsylvania School of Medicine may have found a way to turn an adaptive cellular response… »   

A blood clot preventer from Johnson & Johnson and Bayer caused a surprisingly high rate of bleeding in a trial… »   

Certificates used by Sanofi-Aventis SA to win Genzyme Corp started trading at a steep discount to their best-case value on… »